And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

Tony Ho Biography and Net Worth

VP of CRISPR Therapeutics

Dr. Tony W. Ho M.D. serves as Executive Vice President - Research and Development of the Company. Prior to joining our company, Dr. Ho held a number of roles at AstraZeneca between 2012 and 2017, where he most recently was Senior Vice President and Head of Oncology Integration and Innovation. Before that, he was Vice President and Global Medicine Leader, where he led the development and commercialization of two key drugs for AstraZeneca – Lynparza, a PARP inhibitor for ovarian cancer and Imfinizi (anti-PD-L1), AstraZeneca’s first immuno-oncology drug for bladder cancer. Prior to joining AstraZeneca, Dr. Ho was the Neurology and Ophthalmology Clinical Section Head at Merck Research Laboratories, Merck & Co., Inc. Earlier in his career, Dr. Ho was the co-founder and Chief Scientific Officer of Neuronyx, Inc., a regenerative medicine company. Dr. Ho completed his B.S. in Electrical Engineering at the University of California, Los Angeles, and received his M.D. from the Johns Hopkins University School of Medicine.

What is Tony W. Ho's net worth?: The estimated net worth of Tony W. Ho is at least $2.26 million as of June 23rd, 2020. Dr. Ho owns 40,676 shares of CRISPR Therapeutics stock worth more than $2,263,619 as of April 24th. This net worth approximation does not reflect any other assets that Dr. Ho may own. Learn More about Tony W. Ho's net worth.
How do I contact Tony W. Ho?: The corporate mailing address for Dr. Ho and other CRISPR Therapeutics executives is BAARERSTRASSE 14, ZUG V8, CH-6300. CRISPR Therapeutics can also be reached via phone at (141) 561-3277 and via email at [email protected]. Learn More on Tony W. Ho's contact information.
Has Tony W. Ho been buying or selling shares of CRISPR Therapeutics?: Tony W. Ho has not been actively trading shares of CRISPR Therapeutics during the last ninety days. Learn More on Tony W. Ho's trading history.
Who are CRISPR Therapeutics' active insiders?: CRISPR Therapeutics' insider roster includes Bradley Bolzon (Director), Kurt Emster (Director), Tony Ho (VP), James Kasinger (General Counsel), Lawrence Klein (COO), Samarth Kulkarni (CEO), Rodger Novak (President), and Michael Tomsicek (CFO). Learn More on CRISPR Therapeutics' active insiders.
Are insiders buying or selling shares of CRISPR Therapeutics?: In the last year, insiders at the sold shares 12 times. They sold a total of 203,992 shares worth more than $13,296,584.57. The most recent insider tranaction occured on April, 15th when CEO Samarth Kulkarni sold 19,582 shares worth more than $1,173,157.62. Insiders at CRISPR Therapeutics own 4.1% of the company. Learn More about insider trades at CRISPR Therapeutics.
Information on this page was last updated on 4/15/2024.

Tony W. Ho Insider Trading History at CRISPR Therapeutics

Tony W. Ho Buying and Selling Activity at CRISPR Therapeutics

CRISPR Therapeutics Company Overview

CRISPR Therapeutics is a gene-editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene-editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic collaborations with companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge, Massachusetts, and business offices in San Francisco, California and London, United Kingdom. For more information, please visit www.crisprtx.com.

Today's Range

Now: $55.65

$55.50

$57.77

50 Day Range

MA: $71.75

$55.05

$89.12

2 Week Range

Now: $55.65

$37.55

$91.10

Volume

918,411 shs

Average Volume

1,272,082 shs

Market Capitalization

$4.72 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.76

He Is Giving Away Bitcoin

From Crypto Swap Profits | Ad

>> Register right here